RecruitingNot Applicable

Wearable Devices for Patient Monitoring in Long QT Syndrome

United Kingdom80 participantsStarted 2025-04-01

Plain-language summary

The main research question of this study is whether wearable devices have utility in monitoring patients with Long QT syndrome.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of Long QT Syndrome * Aged 18 years or over * Phone with iOS version 15 or Android OS 9.0 or higher * Able and willing to provide informed consent Exclusion Criteria: * Unwilling or unable to give consent * Ventricular pacing at recruitment * Bundle branch block or pre-excitation at baseline

What they're measuring

1. Determine the accuracy of repeated QT interval measurements using Fitbit-derived ECGs in patients with Long QT syndrome compared with the current standard (12-lead ECG and ambulatory monitors)

Timeframe: From enrollment to 3 months

2. Establish intra-patient QT variability from weekly Fitbit-ECGs and frequency of measurements over 500ms.

Timeframe: From enrollment to 3 months

Trial details

NCT IDNCT06887387

SponsorQueen Mary University of London

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04-30

View on ClinicalTrials.gov More Long QT Syndrome trials